The carcinoma of parathyroid gland

Indian Journal of Cancer

Volumn 41, Issue 2, 2004, Pages 51-59

  Kulkarni, P S ^a   Parikh, P M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Management; Parathyroid carcinoma; Primary hyperparathyroidism

Indexed keywords

CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ESTROGEN; FLUOROURACIL; LOMUSTINE; MITOXANTRONE; TESTOSTERONE; VINCRISTINE;

BIOPSY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; METASTASIS; PARATHYROID CARCINOMA; PARATHYROID GLAND EXAMINATION; PATHOGENESIS; REVIEW; SCINTIGRAPHY; SURVIVAL;

CARCINOMA; HUMANS; NEOPLASM STAGING; PARATHYROID NEOPLASMS;

EID: 4444327074     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. th Ed. Philadelphia: Lippincott Williams and Wilkins; 2001: p. 1763-9.
2. Koea JB, Shaw HF. Parathyroid Cancer: Biology and management. Surgical Oncology 1999;8:155-65.
3. Bilezikian JP, Silverberg SJ. Asymptomatic primary hyperparathyroidism. N Engl J Med 2004;350:1746-51.
4. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton III J. The rise and fall of primary hyperparathyroidism: A population based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997;126:433-40.
5. Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart P, et al. Parathyroid carcinoma. Am J Surg 1998;175:52-5.
6. Dionisi S, Minisola S, Pepe J, Geronimo SD, Paglia F, Memeo L. Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: Presentation as hypercalcemic crisis. Mayo Clin Proc 2002;77:866-9.
7. Shane E. Parathyroid carcinoma. J Clin Endocrinol Metab 2001;86:485-93.
8. Fraker DL. Update on the management of parathyroid tumors. Curr Opin Oncol 2000;12:41-8.
9. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the US between 1985-1995. Cancer 1999;86:538-44.
10. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: Evaluation and interdisciplinary management. Cancer 2004;100:900-5.
11. Shane E, Bilezikian JP. Parathyroid carcinoma: A review of 62 patients. Endocrine Review 1982;3:218-26.
12. Jakoubkova S, Vokurka J, Cap J, Ryska A. Parathyroid carcinoma: Clinical presentation and treatment. International Congress Series 2003;1240:991-5.
13. Al-Sobhi S, Shira H, Al-Dayel F, Ahmed M, Ingemansson S. Parathyroid carcinoma: A report of two cases. Annals of Saudi Medicine 1999;19:431-3.
14. Agrawal R, Agarwal A, Kar DK, Agarwal G, Jain M, Krishnani N, et al. J Assoc Physicians India 2001;49:990-3.
15. Rufener JB, Cohen JI. Metachronous spread of parathyroid carcinoma to a retropharyngeal lymph node. Head and Neck 2003;25:968-71.
16. Khurana AS, Munjal M, Narad M. Parathyroid carcinoma. Indian Journal of Otolaryngology and Head and Neck Surg 2001;53:53-5.
17. Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rastad J. Unique clinical characteristics of primary hyperparathyroidism in India. Br J of Surg 2001;88:708-14.
18. Bhansali A, Kataria RN, Dutta P, Saha MM, Singh P, Dash RJ. Indian J of Cancer 2002;39:119-22.
19. Kameyama K, Takami H. Double parathyroid carcinoma. Endocrine Journal 2003;50:477-9.
20. Christmas TJ, Chapple CR, Noble JG, Milroy EJ, Cowie AG. Hyperparathyroidism after neck irradiation. Br J of Surg 1988;75:873.
21. Nathaniels EK, Nathaniels AM, Wang C. Mediastinal parathyroid tumors: A clinical and pathological study of 84 cases. Ann Surg 1970;171:165.
22. Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid carcinoma - The Princess Margret hospital experience. Int J Radiation Oncology Biol Phys 1998;41:569-72.
23. Tseng CC, Huang JJ, Wang MC, Lan RR, Sung JM, Chen FF. Parathyroid carcinoma with multiple lung metastases. Nephrol Dial Transplant 1999;14:449-51.
24. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Genet 2003;40:657-63.
25. Weinstein LS, Simonds WF. HRPT2, a marker of parathyroid cancer. N Engl J Med 2003;349:1691-2.
26. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003;349:1722-9.
27. Kytola S, Farnebo F, Obara T, Isola J, Grimelius L, Farnebo LV, et al. Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol 2000;157:579-86.
28. Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery AL, et al. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N Engl J Med 1994;330:757-61.
29. Dotzenrath C, Teh BT, Farnebo F, Cupisti K, Svensson A, Toell A, et al. Allelic loss of the retinoblastoma tumor suppressor gene: A marker for aggressive parathyroid tumors? J Clin Endocrinol Metab 1996;81:3194-6.
30. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034-40.
31. Haven CJ, Puijenbroek MV, Karperien M, Fleuren GJ, Morreau H. Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. J of Pathology 2004;202:86-94.
32. Szende B, Farid P, Vegso G, Perner F, Kopper L. Apoptosis and P53, Bcl-2 and Bax gene expression in apr glands of patients with hyperparathyroidism. Pathology Oncology Research 2004;10:98-103.
33. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863-75.
34. Montoro MN, Paler RJ, Goodwin TM, Mestman JH. Parathyroid carcinoma during pregnancy. Obstet Gynecol 2000;96:841.
35. Obara T, Fujimoto Y, Yamaguchi K, Takanashi R, Kino I, Sasaki Y. Parathyroid carcinoma of the oxyphill cell type. A report of two cases, light and electron microscopic study. Cancer 1985;55:1482-9.
36. McKeown PP, McGarity WC, Sewell CW. Carcinoma of the parathyroid gland: Is it overdiagnosed? A report of three cases. Am J of Surg 1984;147:292-7.
37. Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J of Surg Pathol 1993;17:820-9.
38. Kameyama K, Takami H, Umemura S, Osamura YR, Wada N, Sugino K, et al. PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas. Annals of Surg Oncol 2000;7:301-5.
39. th Ed. Hamilton: BC Decker 2003: p. 1295-9.
40. Polat P, Kantarci M, Alper F, Koruyuku M, Suma S, Onbas O. The spectrum of radiographic findings in primary hyperparathyroidism. J of Clin Imaging 2002;26:197-205.
41. Lumachi F, Zucchetta P, Varotto S, Polistina F, Favia G, D'Amico D. Noninvasive localization procedures in ectopic hyperfunctioning parathyroid tumors. Endocr-Relat Cancer 1999;6:123-5.
42. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathroid surgery. J Nucl Med 2003;44:1443-58.
43. Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, et al. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996;81:346-52.
44. Lumachi F, Tregnaghi A, Zucchetta P, Marzola MC, Cecchin D, Marchesi P, et al. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: A prospective clinical study. The Br J of Radiol 2004;77:100-3.
45. Even-Sapir E, Keidar Z, Sachs J, Engel A, Bettman L, Gaitini D, et al. The new technology of combined transmission and emmision tomography in evaluation of endocrine neoplasms. J Nucl Med 2001;42:998-1004.
46. Shaha AR, Shah JP. Parathyroid carcinoma. A diagnostic and therapeutic challenge. Cancer 1999;86:378-80.
47. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, et al. Parathyroid carcinoma: Is there a role for adjuvant radiation therapy? Cancer 2003;98:2378-84.
48. Rasmuson T, Kristoffersson A, Boquist L. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol 2000;143:749-54.
49. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Mark SJ. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel Calcimimetic agent. J Clin Endocrinol Metab 1998;33:1083-8.
50. Cohen A, Silverberg S. Calcimimetics: Therapeutic potential in hyperparathyroidism. Curr Opin Pharmacol 2003;2:734-9.
51. Bradwell AR, Harvey TC. Control of hypercalcemia of parathyroid carcinoma by immunization. Lancet 1999;353:370-3.